Trial Profile
PediCRaFT: Pediatric Crohn's Disease Fecal Microbiota Transplant Pilot Study
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 Oct 2023
Price :
$35
*
At a glance
- Drugs RBX 2660 (Primary) ; RBX 7455 (Primary)
- Indications Crohn's disease
- Focus Adverse reactions; Therapeutic Use
- Acronyms PediCRaFT
- 17 Oct 2023 Status changed from recruiting to completed.
- 23 Apr 2022 Planned End Date changed from 31 Dec 2022 to 31 Mar 2023.
- 23 Apr 2022 Planned primary completion date changed from 31 Jul 2022 to 31 Dec 2022.